Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zoetis (NY:ZTS)

73.92 +0.95 (+1.31%)
Streaming Delayed Price Updated: 12:41 PM EDT, Aug 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
News headline image
Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis (ZTS) Q2 2026 Earnings Call Transcript ↗
U.S. companion animal demand weakened, but livestock and diagnostics surged. 
Via The Motley Fool
Topics Earnings
News headline image
The Top 5 Analyst Questions From Zoetis’s Q2 Earnings Call
Zoetis delivered flat revenue in Q2, missing Wall Street expectations, while its adjusted earnings per share slightly exceeded consensus. The market’s positi... 
Via StockStory
Topics Earnings
Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below. ↗
Via Chartmill
Zoetis (NYSE:ZTS): Dividend Quality Backed by Strong Fundamentals ↗
Via Chartmill
Zoetis Inc (NYSE:ZTS): A Top Value Stock with Undervalued Strength ↗
Via Chartmill
News headline image
2 Large-Cap Stocks for Long-Term Investors and 1 We Avoid
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are... 
Via StockStory
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
News headline image
Zoetis Q2 Earnings Call Highlights ↗
Zoetis (NYSE:ZTS) reported second-quarter revenue of $2.5 billion, flat on a reported basis and down 1% organically, as pressure in U.S. companion-animal categories offset growth in livestock,... 
Via MarketBeat
Topics Earnings
Stay informed with the top movers within the S&P500 index on Friday. ↗
Via Chartmill
Top S&P500 movers in Friday's session ↗
Via Chartmill
News headline image
ZTS Q2 Deep Dive: Leadership Shifts and Competitive Pressures Shape Guidance
Animal health company Zoetis (NYSE:ZTS) fell short of the market’s revenue expectations in Q2 CY2026, with sales flat year on year at $2.47 billion. The comp... 
Via StockStory
These S&P500 stocks are moving in today's session ↗
Via Chartmill
News headline image
Zoetis (NYSE:ZTS) Misses Q2 CY2026 Sales Expectations
Animal health company Zoetis (NYSE:ZTS) fell short of the market’s revenue expectations in Q2 CY2026, with sales flat year on year at $2.47 billion. The comp... 
Via StockStory
News headline image
Zoetis Appoints Jay Saccaro as Chief Financial Officer and Chief Operating Officer
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Announces Second Quarter 2026 Results
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis (ZTS) Reports Q2: Everything You Need To Know Ahead Of Earnings
Animal health company Zoetis (NYSE:ZTS) will be reporting earnings this Thursday before market open. Here’s what you need to know. Zoetis missed analysts’ re... 
Via StockStory
News headline image
ZOETIS CLASS ACTION DEADLINE MONDAY JULY 27th: Bragar Eagel & Squire, P.C. Reminds Zoetis, Inc. Investors to Contact the Firm Before the July 27th Lead Plaintiff Deadline
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Zoetis Inc. (ZTS)
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
3 Healthcare Stocks with Competitive Advantages
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advanceme... 
Via StockStory
News headline image
Deadline Soon: Zoetis Inc. (ZTS) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
ZOETIS INC. INVESTORS WITH LOSSES HAVE UNTIL JULY 27, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Zoetis Launches Portela® (relfovetmab) in Canada and the European Union
From Zoetis Inc.
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zoetis Inc. of Class Action Lawsuit and Upcoming Deadlines – ZTS
From Pomerantz LLP
Via GlobeNewswire
News headline image
ZOETIS CLASS ACTION DEADLINE MONDAY JULY 27th: Bragar Eagel & Squire, P.C. Reminds Zoetis, Inc. Investors to Contact the Firm Before the July 27th Lead Plaintiff Deadline
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
ZTS Deadline: Rosen Law Firm Urges Zoetis Inc. (NYSE: ZTS) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
ZOETIS DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ZTS
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
ZOETIS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ZTS
From The Rosen Law Firm PA
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.